The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Dragonflies Smarter Than We Thought
Researchers in Australia have found evidence that the dragonfly is capable of higher-level thought processes when hunting its prey.
Chinese Researcher: Pollution In China More Frightening Than SARS
An eminent Chinese academic who played a central role during the 2003 SARS outbreak in China says that air pollution may be more deadly than SARS.
Pulitzer-Winning Author Jared Diamond Writes Book On New Guinea Adventures
Celebrated author and anthropologist Jared Diamond has written a new book on his decades of field work in the Pacific Islands of New Guinea.
Indonesia Opens First Shark And Manta Ray Sanctuary
The 46,000 square kilometer sanctuary is the first to be established in the Coral Triangle, and also provides protection to dugongs, whales, turtles, and dolphins.
Gut Microbes Could Influence Survival In Melamine Scandal
Scientists have discovered a clue as to why some children survived the melamine-contaminated milk scandal in China.
Is Cloud Seeding Preventing Further Flooding In Indonesia?
Indonesia is banking on an unusual strategy to prevent further flooding in its inundated capital Jakarta called cloud seeding.
Love Of Music & Harmony Can Be Learnt, Study
Our love of music and appreciation of musical harmony is learnt and not based on natural ability, says a new study.
Cold Air And Wasabi Linked To Longer Lifespan In Worms, Study
Cool temperatures and the spicy condiment wasabi activate a protein that increases the lifespans of nematode worms, according to a new study.
Pfizer To Conduct NSCLC Drug Trial In Asia
Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.